Home LiteratureArticle Details
PMID: 11083836 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages.

Infection and immunity ·Vol. 68 ·No. 12 ·2000-12-00 ·Pages 7100-13

Garrity-Ryan L, Kazmierczak B, Kowal R, Comolli J, Hauser A, Engel JN

Abstract

Pseudomonas aeruginosa, an important nosocomial pathogen of humans, expresses a type III secretion system that is required for virulence. Previous studies demonstrated that the lung-virulent strain PA103 has the capacity to be either cytotoxic or invasive. Analyses of mutants suggest that PA103 delivers a negative regulator of invasion, or anti-internalization factor, to host cells via a type III secretion system. In this work we show that the type III secreted protein ExoT inhibits the internalization of PA103 by polarized epithelial cells (Madin-Darby canine kidney cells) and J774.1 macrophage-like cells. ExoS, which is closely related to ExoT but has additional ADP-ribosylating activity, can substitute for ExoT as an anti-internalization factor. ExoT contains a signature arginine finger domain found in GTPase-activating proteins. Mutation of the conserved arginine in ExoT diminished its anti-internalization activity and altered its ability to disrupt the actin cytoskeleton. Cell fractionation experiments showed that ExoT is translocated into host cells and that mutation of the arginine finger did not disrupt translocation. In a mouse model of acute pneumonia, PA103DeltaUDeltaT reached the lungs as efficiently as PA103DeltaU but showed reduced colonization of the liver. This finding suggests that the ability to resist internalization may be important for virulence in vivo.

MeSH Terms
ADP Ribose Transferases Actins/metabolism Animals Arginine Bacterial Toxins/toxicity Biological Transport Cytoplasm/metabolism Cytoskeleton/physiology Exotoxins/chemistry,toxicity Female HeLa Cells Humans Macrophages/microbiology Mice Mice, Inbred BALB C Pseudomonas aeruginosa/pathogenicity Virulence Virulence Factors
Chemicals
Actins Bacterial Toxins Exotoxins Virulence Factors Arginine ADP Ribose Transferases toxA protein, Pseudomonas aeruginosa
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Garrity-Ryan L
Department of Medicine, Department of Microbiology and Immunology, and the Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California 94143, USA.
Kazmierczak B
Kowal R
Comolli J
Hauser A
Engel J N
References (53)
53 references, click to expand
  1. The N-terminal domain of Pseudomonas aeruginosa exoenzyme S is a GTPase-activating protein for Rho GTPases.
    J Biol Chem. 1999 Dec 17;274(51):36369-72 PMID: 10593930
  2. Type III machines of pathogenic yersiniae secrete virulence factors into the extracellular milieu.
    Mol Microbiol. 1999 Mar;31(6):1619-29 PMID: 10209737
  3. GAP activity of the Yersinia YopE cytotoxin specifically targets the Rho pathway: a mechanism for disruption of actin microfilament structure.
    Mol Microbiol. 2000 May;36(3):737-48 PMID: 10844661
  4. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence.
    Mol Microbiol. 2000 Aug;37(3):515-27 PMID: 10931345
  5. Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein.
    Infect Immun. 2000 Oct;68(10):6066-8 PMID: 10992524
  6. Rho GTPase activity modulates Pseudomonas aeruginosa internalization by epithelial cells.
    Cell Microbiol. 2001 Feb;3(2):85-98 PMID: 11207623
  7. Pseudomonas aeruginosa ExoT inhibits in vitro lung epithelial wound repair.
    Cell Microbiol. 2001 Apr;3(4):223-36 PMID: 11298646
  8. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.
    J Infect Dis. 1966 Oct;116(4):481-9 PMID: 4959184
  9. The amino-terminal domain of Pseudomonas aeruginosa ExoS disrupts actin filaments via small-molecular-weight GTP-binding proteins.
    Mol Microbiol. 1999 Apr;32(2):393-401 PMID: 10231494
  10. Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.
    Infect Immun. 1999 Oct;67(10):5530-7 PMID: 10496945
  11. A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion.
    Nature. 1999 Sep 16;401(6750):293-7 PMID: 10499590
  12. YopH dephosphorylates Cas and Fyn-binding protein in macrophages.
    Microb Pathog. 1999 Oct;27(4):231-42 PMID: 10502464
  13. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  14. Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A.
    Proc Natl Acad Sci U S A. 1978 Jul;75(7):3211-5 PMID: 210453
  15. Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice.
    Infect Immun. 1979 Jun;24(3):837-42 PMID: 112058
  16. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12.
    Nature. 1985 Sep 19-25;317(6034):262-4 PMID: 2995819
  17. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin.
    Proc Natl Acad Sci U S A. 1987 May;84(9):2833-7 PMID: 2883655
  18. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells.
    Cell. 1990 Mar 9;60(5):861-71 PMID: 2311122
  19. The cytotoxic protein YopE of Yersinia obstructs the primary host defence.
    Mol Microbiol. 1990 Apr;4(4):657-67 PMID: 2191183
  20. Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia.
    Science. 1990 Aug 3;249(4968):553-6 PMID: 2166336
  21. Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection.
    Infect Immun. 1994 Aug;62(8):3485-93 PMID: 8039920
  22. Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa.
    Gene. 1994 Oct 11;148(1):81-6 PMID: 7926843
  23. Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing.
    Infect Immun. 1995 Apr;63(4):1541-51 PMID: 7890421
  24. Glucosylation of Rho proteins by Clostridium difficile toxin B.
    Nature. 1995 Jun 8;375(6531):500-3 PMID: 7777059
  25. An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa.
    Gene. 1995 May 26;158(1):15-22 PMID: 7789804
  26. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro.
    Infect Immun. 1995 Oct;63(10):4072-7 PMID: 7558321
  27. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections.
    Science. 1996 Jan 5;271(5245):64-7 PMID: 8539601
  28. Origins of cell polarity.
    Cell. 1996 Feb 9;84(3):335-44 PMID: 8608587
  29. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
    J Bacteriol. 1996 Mar;178(5):1412-9 PMID: 8631719
  30. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa.
    Infect Immun. 1996 Jun;64(6):2288-94 PMID: 8675339
  31. Requirement of CDC42 for Salmonella-induced cytoskeletal and nuclear responses.
    Science. 1996 Dec 20;274(5295):2115-8 PMID: 8953049
  32. Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S.
    Infect Immun. 1997 Feb;65(2):579-86 PMID: 9009316
  33. The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions.
    EMBO J. 1997 May 1;16(9):2307-18 PMID: 9171345
  34. Common themes in microbial pathogenicity revisited.
    Microbiol Mol Biol Rev. 1997 Jun;61(2):136-69 PMID: 9184008
  35. Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions.
    EMBO J. 1997 May 15;16(10):2730-44 PMID: 9184219
  36. Identification of Pseudomonas aeruginosa genes required for epithelial cell injury.
    Mol Microbiol. 1997 Jun;24(6):1249-62 PMID: 9218773
  37. IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia.
    J Immunol. 1997 Sep 15;159(6):2858-66 PMID: 9300709
  38. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung.
    Proc Natl Acad Sci U S A. 1997 Oct 28;94(22):12088-93 PMID: 9342367
  39. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments.
    Mol Microbiol. 1997 Sep;25(6):1125-39 PMID: 9350868
  40. Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon.
    J Bacteriol. 1997 Nov;179(22):7165-8 PMID: 9371466
  41. PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence.
    Mol Microbiol. 1998 Feb;27(4):807-18 PMID: 9515706
  42. Defects in type III secretion correlate with internalization of Pseudomonas aeruginosa by epithelial cells.
    Infect Immun. 1998 Apr;66(4):1413-20 PMID: 9529061
  43. Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both of which involve protein tyrosine kinase activity.
    Infect Immun. 1998 Apr;66(4):1453-9 PMID: 9529067
  44. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells.
    Cell. 1998 May 29;93(5):815-26 PMID: 9630225
  45. Targeting of Yersinia Yop proteins into the cytosol of HeLa cells: one-step translocation of YopE across bacterial and eukaryotic membranes is dependent on SycE chaperone.
    Mol Microbiol. 1998 May;28(3):593-601 PMID: 9632261
  46. Role of alveolar macrophages in initiation and regulation of inflammation in Pseudomonas aeruginosa pneumonia.
    Infect Immun. 1998 Jul;66(7):3164-9 PMID: 9632581
  47. In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections.
    Infect Immun. 1998 Jul;66(7):3242-9 PMID: 9632591
  48. Identification and characterization of SpcU, a chaperone required for efficient secretion of the ExoU cytotoxin.
    J Bacteriol. 1998 Dec;180(23):6224-31 PMID: 9829931
  49. Enteropathogenic Escherichia coli inhibits phagocytosis.
    Infect Immun. 1999 Feb;67(2):490-5 PMID: 9916050
  50. Regulation of ExoS production and secretion by Pseudomonas aeruginosa in response to tissue culture conditions.
    Infect Immun. 1999 Feb;67(2):914-20 PMID: 9916108
  51. A built-in arginine finger triggers the self-stimulatory GTPase-activating activity of rho family GTPases.
    J Biol Chem. 1999 Jan 29;274(5):2609-12 PMID: 9915787
  52. Biological effects of Pseudomonas aeruginosa type III-secreted proteins on CHO cells.
    Infect Immun. 1999 Apr;67(4):2040-4 PMID: 10085057
  53. ExoT of cytotoxic Pseudomonas aeruginosa prevents uptake by corneal epithelial cells.
    Infect Immun. 2000 Jan;68(1):403-6 PMID: 10603417
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2000-12-00
Pages
7100-13
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC97821
Subset
IM
Grants
NIAID NIH HHS · R01 AI042806 · United States
NIAID NIH HHS · AI R01 AI42806 · United States
NIAID NIH HHS · K08 AI001524 · United States
NIAID NIH HHS · K08 AI01636 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com